INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple threat: new combo tackles untreatable liver cancer
Disease control Not yet recruitingThis study tests a three-drug combination for people with a type of liver cancer that cannot be removed by surgery. The treatment includes chemotherapy delivered directly to the liver, plus two other drugs taken by mouth and through a vein. The goal is to see if this combination …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 17, 2026 01:34 UTC
-
New pill shows promise against rare bile duct cancer in Late-Stage trial
Disease control Not yet recruitingThis study tests a new oral drug, TT-00420, against standard chemotherapy for people with advanced bile duct cancer that has a specific genetic change (FGFR2). The trial includes 138 adults whose cancer worsened after initial treatment. The goal is to see if the new drug can slow…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: PHASE3 • Sponsor: TransThera Sciences (Nanjing), Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New ultrasound method aims to catch bile duct cancer spread before surgery
Knowledge-focused Not yet recruitingThis study looks at whether an improved endoscopic ultrasound (EUS) procedure can better find cancer in lymph nodes of people with bile duct cancer before they have surgery. About 250 adults with certain types of bile duct cancer that might be removable will get this special ultr…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Sponsor: Erasmus Medical Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
New tool could guide surgery decisions for tough liver cancer
Knowledge-focused Not yet recruitingThis study looks at 270 people with a type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be removed right away. After initial chemotherapy, doctors will use a special evaluation system (TDTP-RECIST) to decide whether to continue medication or perform surgery. The …
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA (ICC)
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC